| Financial Year |
March 31 2023 |
| Monetary Funds |
203,088,864.63 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
45,910,329.78 |
| Accounts Receivable |
289,111,461.44 |
| Advances to Suppliers |
3,126,195.55 |
| Other Receivables |
206,257,401.35 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
19,873,342.93 |
| Inventories |
117,197,022.67 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
234,528,610.30 |
| Other Current Assets |
28,240,824.23 |
| Total Current Assets |
1,129,827,429.81 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
84,972,254.35 |
| Investment Properties |
7,736,498,201.40 |
| Fixed Assetes |
112,003,135.30 |
| Under-construction Projects |
74,953,790.61 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
31,882,619.13 |
| R&D expenses |
-- |
| Goodwill |
218,774,514.53 |
| Long-Term Deferred and Prepaid Expenses |
41,353,270.12 |
| Deferred Income Tax Assets |
332,916,375.13 |
| Other Non-Current Assets |
58,500,277.85 |
| Sub-Total of Non-Current Assets |
9,050,611,600.41 |
| Total Assets |
10,180,439,030.22 |
| Short-Term Loans |
409,510,723.95 |
| Trading Financial liabilities |
-- |
| Notes Payable |
38,000,000.00 |
| Accounts Payable |
136,532,826.92 |
| Accounts Received In Advance |
58,939,528.49 |
| Employee Compensation Payable |
12,768,029.68 |
| Taxes Payable |
54,327,678.24 |
| Interest Payable |
1,002,661,333.56 |
| Dividend Payable |
-- |
| Other payables |
1,953,479,511.38 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,606,054,180.29 |
| Other Current Liabilities |
43,274,293.73 |
| Sub-Total of Current Liabilities |
6,331,987,396.16 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
276,099,932.76 |
| Special Payable |
-- |
| Estimatied Liabilities |
162,469,838.74 |
| Deferred Income Tax Liabilities |
1,092,379,979.84 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,851,546,155.42 |
| Total Liabilities |
8,183,533,551.58 |
| Paid-In Capital(Or Share Stock) |
1,210,088,720.00 |
| Capital Surplus |
1,783,303,262.41 |
| Surplus Reserve |
144,221,372.70 |
| LESS:Treasury Stock |
273,964,374.07 |
| Undistributed Profits |
-610,785,903.64 |
| Minority Stockholder's Interest |
-1,004,158.60 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,997,909,637.24 |
| Owner's Equity（Stockholder's Equity） |
1,996,905,478.64 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
10,180,439,030.22 |
